Pulmonary Hypertension: Intensification and Personalisation of Combination Rx

NCT05825417 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Selexipag
DRUG: Riociguat
DEVICE: CardioMEMS pulmonary artery pressure monitor
DEVICE: Confirm Rx

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]